Figure 4.
Twelve-month adherence to index antidiabetic drug classes in (A) UT patients and (B) PT patients in the JMDC and MDV databases. α-GI, α-glucosidase inhibitor; BG, biguanide; DPP-4i, dipeptidyl peptidase-4 inhibitor; JMDC, Japan Medical Data Center; MDV, Medical Data Vision; PT, previously treated; pts, patients; SGLT2i, sodium-glucose cotransporter-2 inhibitor; SU, sulfonylurea; TZD, thiazolidinedione; UT, untreated.